Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Mouse Anti-TNFRSF21 Recombinant Antibody (8A6) (CBMAB-A9327-LY)

The product is antibody recognizes TNFRSF21. The antibody 8A6 immunoassay techniques such as: ELISA.
Host Species
Mouse
Application
ELISA
Immunogen
TNFRSF21 (AAH17730.1, 89 a.a. ~ 170 a.a) partial recombinant protein.
Antibody Isotype
IgG1, κ
Specificity
Human
Clone
8A6
Format
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.
Introduction
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors. Knockout studies in mice suggested that this gene plays a role in T-helper cell activation, and may be involved in inflammation and immune regulation. [provided by RefSeq]
Alternative Name
BM-018; DR6; MGC31965
Entrez Gene ID
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Submit a review Submit a review and you will get a coupon.
0 reviews
Loading...

Please try the standard protocols which include: protocols, troubleshooting and guide.

Click here to view the protocols, troubleshooting and guide.

Cat CBMAB-A9327-LY
Conjugates
Size
Price $
  ADD TO CART
Request bulk or custom quote
Second antibody and isotype control